Unified care and integrated treatments for ADHD with substance use in prison settings
Official title: Unified Junction of Care, Integrated Treatments and Team Coordination for ADHD in Prison Settings With Substance Use Disorder
Run by University Hospital, Brest · NCT07487155 · Data updated 2026-11-12
Aimed at people under correctional supervision who have ADHD and substance use disorder, this program tests a coordinated care approach to improve identification and support.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 39 (estimated) |
| Sponsor | University Hospital, Brest Academic / other |
| Locations | 1 site (Brest) |
| Status | Recruiting |
| Started | August 3, 2026 |
| Main results expected | January 1, 2028 |
| Study ends | January 1, 2028 |
| Registry record updated | August 11, 2026 |
| Trial ID | NCT07487155 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults under correctional supervision with diagnosed SUD and ADHD who understand French and consent to participate.
✕Probably not a fit
Individuals without ADHD or SUD, those with severe psychiatric decompensation, or those unable to participate in the workshop may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional program targets adults under justice system supervision who have both ADHD and a substance use disorder. It tests a workshop-based approach delivered within a correctional or monitored setting to improve detection and care coordination for these co-occurring conditions. The study emphasizes teamwork, integrated treatment planning, and streamlined care pathways to address social and legal vulnerabilities. Recruitment includes individuals with SUD and ADHD who are language-proficient in French and not excluded by severe psychiatric or cognitive impairment. The lead site is CHU Brest in Brest, France, under the University Hospital of Brest.
Why it matters
Potential benefit: If successful, participants may receive more coordinated and timely support for ADHD and SUD, potentially improving management and outcomes.
How similar studies have gone: Previous work supports integrated, team-based approaches for co-occurring conditions in high-vulnerability populations, but this exact prison-based, ADHD-SUD integration is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult, under the supervision of the justice system or monitored by a correctional facility * Diagnosis of Substance Use Disorder (SUD) * Diagnosis of Attention Deficit Hyperactivity Disorder (ADHD) * No objection from the patient * Affiliated with a Social Security system Exclusion Criteria: * Severe or decompensated psychiatric disorders * Severe cognitive impairment * Lack of understanding of the French language * Refusal to participate
Where it's running
-
CHU Brest
Brest, France Recruiting
Study contacts
- Principal investigator: Morgane GUILLOU-LANDREAT, MD — CHU Brest
- Study coordinator: Marie BARAIS, MD
- Email: marie.barais@gmail.com
- Phone: +332 98 01 64 02
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Project SHIELD 2.0: Police Education to Support Public Health in Kentucky
Aimed at police in Kentucky, this program tests whether SHIELD training given to officers, with health workers helping deliver it, can reduce drug-related arrests and steer people who use drugs toward MOUD and other health services.
-
Real-time fMRI Neurofeedback for Anhedonia in Methadone-Treated Opioid Use Disorder
This feasibility study tests a real-time fMRI neurofeedback approach to see if it helps reduce anhedonia in people on methadone for opioid use disorder.
-
Trauma recovery options for veterans: comparing HRV biofeedback and present-centered therapy
This trial tests whether Heart Rate Variability Biofeedback plus trauma-informed care helps veterans with PTSD and substance use issues more than present-centered therapy.
-
ALKS 7290 vs placebo in adults with ADHD
This trial tests whether ALKS 7290 can help adults with ADHD better than a placebo.
-
Connecting Loved Ones to Support and Empower Recovery
A web-based program called KulaMind-Recovery tests whether guided online training, one-on-one coaching, and a community forum help loved ones support someone with a substance use disorder.
-
Next-Generation Dome Helmet for Focused Ultrasound Neuromodulation in Treatment-Resistant Substance Use Disorder
This study tests whether focused ultrasound delivered through a Dome Helmet can be safely used to target brain regions and help adults with hard-to-treat substance use disorders see if their use declines.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.